These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23124107)

  • 41. Relationship between critical relative humidity and solubility of drugs.
    Wang Y; Zhan X; Luo L; Chen J; Xiang C; Li C; Li L
    Drug Dev Ind Pharm; 2011 May; 37(5):547-51. PubMed ID: 21126222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predicting the API partitioning between lipid-based drug delivery systems and water.
    Brinkmann J; Becker I; Kroll P; Luebbert C; Sadowski G
    Int J Pharm; 2021 Feb; 595():120266. PubMed ID: 33486017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Findings of the challenge to predict aqueous solubility.
    Hopfinger AJ; Esposito EX; Llinàs A; Glen RC; Goodman JM
    J Chem Inf Model; 2009 Jan; 49(1):1-5. PubMed ID: 19117422
    [No Abstract]   [Full Text] [Related]  

  • 44. Handling of computational in vitro/in vivo correlation problems by Microsoft Excel: V. Predictive absorbability models.
    Langenbucher F
    Eur J Pharm Biopharm; 2007 Aug; 67(1):293-9. PubMed ID: 17363230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.
    Jónsdóttir SO; Jørgensen FS; Brunak S
    Bioinformatics; 2005 May; 21(10):2145-60. PubMed ID: 15713739
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What determines drug solubility in lipid vehicles: is it predictable?
    Rane SS; Anderson BD
    Adv Drug Deliv Rev; 2008 Mar; 60(6):638-56. PubMed ID: 18089295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. "Innovative processes for bio-pharmaceuticals and poorly water-soluble API".
    Müller-Goymann C; Kwade A
    Eur J Pharm Biopharm; 2018 May; 126():1. PubMed ID: 29474867
    [No Abstract]   [Full Text] [Related]  

  • 49. Calculation of aqueous solubility of crystalline un-ionized organic chemicals and drugs based on structural similarity and physicochemical descriptors.
    Raevsky OA; Grigor'ev VY; Polianczyk DE; Raevskaja OE; Dearden JC
    J Chem Inf Model; 2014 Feb; 54(2):683-91. PubMed ID: 24456022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
    Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
    Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.
    Elder DP; Holm R; Diego HL
    Int J Pharm; 2013 Aug; 453(1):88-100. PubMed ID: 23182973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physico-chemical properties of aqueous drug solutions: From the basic thermodynamics to the advanced experimental and simulation results.
    Bellich B; Gamini A; Brady JW; Cesàro A
    Int J Pharm; 2018 Apr; 540(1-2):65-77. PubMed ID: 29412151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brief overview of solubility methods: Recent trends in equilibrium solubility measurement and predictive models.
    Könczöl Á; Dargó G
    Drug Discov Today Technol; 2018 Jul; 27():3-10. PubMed ID: 30103861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
    Blagden N; de Matas M; Gavan PT; York P
    Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of suitable formulations for high dose oral studies in rats using in vitro solubility measurements, the maximum absorbable dose model, and historical data sets.
    Wuelfing WP; Kwong E; Higgins J
    Mol Pharm; 2012 May; 9(5):1163-74. PubMed ID: 22394323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of aqueous solubility of drugs and pesticides with COSMO-RS.
    Klamt A; Eckert F; Hornig M; Beck ME; Bürger T
    J Comput Chem; 2002 Jan; 23(2):275-81. PubMed ID: 11924739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative structure/property relationship analysis on aqueous solubility using genetic algorithm-combined partial least squares method.
    Wanchana S; Yamashita F; Hashida M
    Pharmazie; 2002 Feb; 57(2):127-9. PubMed ID: 11878188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review of the cosolvency models for predicting solubility of drugs in water-cosolvent mixtures.
    Jouyban A
    J Pharm Pharm Sci; 2008; 11(1):32-58. PubMed ID: 18445363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of (1)H NMR to facilitate solubility measurement for drug discovery compounds.
    Lin M; Tesconi M; Tischler M
    Int J Pharm; 2009 Mar; 369(1-2):47-52. PubMed ID: 19073245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New ideas about the solubility of drugs.
    Box K; Comer JE; Gravestock T; Stuart M
    Chem Biodivers; 2009 Nov; 6(11):1767-88. PubMed ID: 19937815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.